Results 231 to 240 of about 3,220,825 (277)
Some of the next articles are maybe not open access.
ROLE OF FIBRINOLYTIC AGENTS IN THROMBOTIC DISEASES
Journal of the American Medical Association, 1960Critical analysis of existing data demonstrates that fibrinolysin in conjunction with anticoagulant therapy decreases the morbidity in patients with thrombophlebitis. This conclusion was the result of comparison of data from hospital charts of 20 patients in a fibrinolysin-treated series and a control group of 22 patients. The comparison was made after
R. V. Chapple, H. O. Singher
openaire +3 more sources
Monitoring activity of fibrinolytic agents
The American Journal of Medicine, 1984The recognition that thrombolytic therapy may be beneficial for coronary thrombolysis has led to an increased use of plasminogen activators in critically ill patients, sometimes with inadequate monitoring. This review delineates the components of the fibrinolytic system, describes mechanisms of fibrinolysis, and presents practical guidelines for ...
Kenneth E. Shafer +3 more
openaire +3 more sources
New fibrinolytic agents for MI: as effective as current agents, but easier to administer.
Cleveland Clinic journal of medicine, 2004The efficacy and safety of fibrinolytic agents have not dramatically changed since alteplase (Activase), a derivative of tissue plasminogen activator (t-PA), was introduced nearly 2 decades ago.
Keith Ellis, S. Brener
semanticscholar +1 more source
Local Release of Fibrinolytic Agents for Adhesion Prevention
Journal of Surgical Research, 1995Tissue plasminogen activator (tPA), urokinase plasminogen activator (uPA), and streptokinase were evaluated for their ability to reduce postsurgical adhesion formation in a rat uterine horn devascularization and serosal injury model in a blinded, randomized study.
Randall C. Dunn +2 more
openaire +3 more sources
Safety and Efficacy of Fibrinolytic Agents in Acute Ischemic Stroke
, 1993The modern concepts of recanalization strategies by using fibrinolytic agents are discussed.
E. Mori
semanticscholar +1 more source
American Journal of Respiratory Cell and Molecular Biology, 1999
Incorporation of surfactant into polymerizing fibrin causes loss of surface activity and marked retardation of clot lysis by plasmin (Günther and colleagues, Am. J. Physiol. 1994;267:L618-L624).
A. Günther +5 more
semanticscholar +1 more source
Incorporation of surfactant into polymerizing fibrin causes loss of surface activity and marked retardation of clot lysis by plasmin (Günther and colleagues, Am. J. Physiol. 1994;267:L618-L624).
A. Günther +5 more
semanticscholar +1 more source
1978
The prophylaxis and treatment of thromboembolic disorders have long involved the use of anticoagulants administered either parenterally or via the oral route. However, at the present time, there is no longer unanimity regarding the effectiveness of this medication, due to the difficulties of objective assessment of all of the parameters of ...
openaire +2 more sources
The prophylaxis and treatment of thromboembolic disorders have long involved the use of anticoagulants administered either parenterally or via the oral route. However, at the present time, there is no longer unanimity regarding the effectiveness of this medication, due to the difficulties of objective assessment of all of the parameters of ...
openaire +2 more sources
Quantitation of fibrinolytic agents released in tissue culture
Experientia, 1971Es wird eine neue Methode zur Bestimmung der freigesetzten Menge fibrinolytisch wirksamer Stoffe in Gewebekulturen beschrieben. Das Gewebe wird in Leightonrohrchen mit einem standardisierten Fibringerinnsel gezuchtet. Die abgebaute Fibrinmenge — als Mass der fibrinolytischen Aktivitat — wird durch immunologische Bestimmung der Spaltprodukte gemessen.
Inga Marie Nilsson +2 more
openaire +3 more sources
The treatment of cerebrovascular thromboses and embolism with fibrinolytic agents
The American Journal of Cardiology, 1960H UMAN fibrinolysin and streptokinaset have been shown to dissolve fresh intravascular thrombi in several pathologic situations.1-3 These agents have been administered to extremely ill patients without serious side effects. Our results and those of others in treatment of patients with peripheral thrombophlebitis, peripheral arterial thrombosis and ...
Robert L. Clarke, Eugene E. Cliffton
openaire +3 more sources